NewAmsterdam Pharma Company N.V. (NAMS) has a market capitalization of $3.96B and trades at $34.44. The 52-week range is 14.06-42.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -19.7, Earnings Per Share (EPS) of $-1.75, annual revenue of $22.5M.
The stock has a beta of 0.13, operates in the Healthcare sector.
